From: Concurrent hyperfractionated chemoradiotherapy for head and neck squamous cell carcinoma: the prognostic impact of the overall treatment time and completion rates of chemotherapy
Days
Intermission days of RT n (%)
Days of RT without carboplatin n (%)
0
37 (54)
27 (39)
1–5
8 (12)
13 (19)
6–10
12 (7)
11–20
11 (16)
21–
1 (1)
3 (4)